logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sabina Murgioni

Veneto Institute of Oncology IOV-IRCCS
H指数:19
被引数:1,630

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Zanidatamab vs trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis

赞尼达他马 vs 曲妥珠单抗联合或不联合PD-1阻断剂在HER2阳性转移性胃癌中的比较：一项重建的患者水平合并分析

Oncologist
IF4.2
2026-07-140
OAAI
Federico Nichetti; Floriana Nappo; Francesca Bof; Martina Bosa; Elena Mattiuzzo; Giulia Maddalena; Maria Caterina De Grandis; Sabina Murgioni; Francesca Bergamo; Sara Lonardi; null
Locoregional treatment of esophageal oligometastatic disease to the liver: single center experience, a systematic review and meta-analysis.

食管寡转移性病变的肝转移局部区域治疗：单中心经验、系统评价和荟萃分析。

European Journal of Surgical Oncology
IF2.9
2025-10-240
PRE
Giulia Nezi; Matteo Pittacolo; Lucia Moletta; Renato Salvador; Elisa Sefora Pierobon; Luca Provenzano; Gianpietro Zanchettin; Giovanni Capovilla; Arianna Vittori; Francesca Forattini; Sara Lonardi; Sabina Murgioni; Sara Galuppo; Luca Bellaio; Enrico Gringeri; Umberto Cillo; Michele Valmasoni
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

曲美木单抗和度伐利尤单抗作为微卫星不稳定性高、可切除的胃或胃食管结合部腺癌患者的新辅助治疗或非手术治疗策略：GONO开展的INFINITY研究

ANNALS OF ONCOLOGY
IF65.4
2025-03-018
PRE
Raimondi, A.; Lonardi, S.; Murgioni, S.; Cardellino, G. G.; Tamberi, S.; Strippoli, A.; Palermo, F.; De Manzoni, G.; Bencivenga, M.; Bittoni, A.; Chiodoni, C.; Lorenzini, D.; Todoerti, K.; Manca, P.; Sangaletti, S.; Prisciandaro, M.; Randon, G.; Nichetti, F.; Bergamo, F.; Brich, S.; Belfiore, A.; Bertolotti, A.; Stetco, D.; Guidi, A.; Torelli, T.; Vingiani, A.; Joshi, R. P.; Khoshdeli, M.; Beaubier, N.; Stumpe, M. C.; Nappo, F.; Leone, A. G.; Pircher, C. C.; Leoncini, G.; Sabella, G.; Farulla, L. Airo'; Alessi, A.; Morano, F.; Martinetti, A.; Niger, M.; Fassan, M.; Di Maio, M.; Kaneva, K.; Milione, M.; Nimeiri, H.; Sposito, C.; Agnelli, L.; Mazzaferro, V.; Di Bartolomeo, M.; Pietrantonio, F.
Multicentre, multi-cohort, single-arm phase II trial of tremelimumab and durvalumab as neoadjuvant or definitive treatment of patients (pts) with microsatellite instabilityhigh (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC): The INFINITY study
ANNALS OF ONCOLOGY
IF65.4
2024-06-010
PRE
Raimondi, A.; Lonardi, S.; Murgioni, S.; Cardellino, G.; Passardi, A.; Demanzoni, G.; Strippoli, A.; Palermo, F.; Prisciandaro, M.; Bergamo, F.; Garattini, S. K.; Frassineti, G. L.; Bencivenga, M.; Randon, G.; Leone, A. G.; Nappo, F.; Mazzaferro, V.; Sposito, C. F.; Morano, F.; Pietrantonio, F.
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action
GASTRIC CANCER
IF5.1
2023-06-292
PRE
Fornaro, Lorenzo; Lonardi, Sara; Catanese, Silvia; Nappo, Floriana; Pietrantonio, Filippo; Pellino, Antonio; Angerilli, Valentina; Signorini, Francesca; Salani, Francesca; Murgioni, Sabina; Neculaescu, Ioana Ancuta; Bruno, Rossella; Vivaldi, Caterina; Ricagno, Gianmarco; Masi, Gianluca; Bergamo, Francesca; Ugolini, Clara; Fassan, Matteo
Gut microbiome composition as predictor of the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the AtezoTRIBE study
ANNALS OF ONCOLOGY
IF65.4
2023-06-010
OA
Marmorino, F.; Piccinno, G.; Rossini, D.; Ghelardi, F.; Murgioni, S.; Salvatore, L.; Nasca, V.; Antoniotti, C.; Daniel, F.; Schietroma, F.; Conca, V.; Silva, C. Alves Costa; Tamburini, E.; Tamberi, S.; Passardi, A.; Carullo, M.; Antonuzzo, L.; D'Onofrio, R.; Zitvogel, L.; Cremolini, C.; Derosa, L.
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
CLINICAL CANCER RESEARCH
IF10.2
2023-04-069
OA
Antoniotti, Carlotta; Boccaccino, Alessandra; Seitz, Robert; Giordano, Mirella; Catteau, Aurelie; Rossini, Daniele; Pietrantonio, Filippo; Salvatore, Lisa; McGregor, Kimberly; Bergamo, Francesca; Conca, Veronica; Leonetti, Simone; Morano, Federica; Papiani, Giorgio; Tamburini, Emiliano; Bensi, Maria; Murgioni, Sabina; Ross, Douglas Teller; Passardi, Alessandro; Boquet, Isabelle; Nielsen, Tyler J.; Galon, Jerome; Varga, Matthew Gordon; Schweitzer, Brock L.; Cremolini, Chiara
Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients

肿瘤学的同时护理: 评估753患者的症状，性别和年龄相关的益处

FRONTIERS IN ONCOLOGY
IF3.3
2022-10-147
OAAI
Galiano, Antonella; Schiavon, Stefania; Nardi, Mariateresa; Guglieri, Irene; Pambuku, Ardi; Martino, Rosalba; Bolshinsky, Maital; Murgioni, Sabina; Intini, Rossana; Solda, Caterina; Marino, Dario; Daniel, Francesca; De Toni, Chiara; Pittarello, Chiara; Chiusole, Benedetta; Prete, Alessandra Anna; Bimbatti, Davide; Nappo, Floriana; Caccese, Mario; Bergamo, Francesca; Brunello, Antonella; Lonardi, Sara; Zagonel, Vittorina
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas

CLDN18蛋白表达与进展期胃癌及胃食管交界处腺癌临床病理特征及预后的相关性

JOURNAL OF PERSONALIZED MEDICINE
IF3
2021-10-2680
OAAI
Pellino, Antonio; Brignola, Stefano; Riello, Erika; Niero, Monia; Murgioni, Sabina; Guido, Maria; Nappo, Floriana; Businello, Gianluca; Sbaraglia, Marta; Bergamo, Francesca; Spolverato, Gaya; Pucciarelli, Salvatore; Merigliano, Stefano; Pilati, Pierluigi; Cavallin, Francesco; Realdon, Stefano; Farinati, Fabio; Dei Tos, Angelo Paolo; Zagonel, Vittorina; Lonardi, Sara; Loupakis, Fotios; Fassan, Matteo
Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial
ANNALS OF ONCOLOGY
IF65.4
2021-09-010
OAAI
Lai, E.; Murgioni, S.; Ziranu, P.; Basile, D.; Cherri, S.; Madeddu, C.; Bergamo, F.; Piacentini, G.; Smiroldo, V.; Squadroni, M.; De Grandis, M. C.; Mascia, L.; Rosati, G.; Zampino, M. G.; Spallanzani, A.; Conca, V.; Palladino, M. A.; Flaminio, V.; Di Bella, S.; Scartozzi, M.
MAYA trial: Temozolomide (TMZ) priming followed by combination with low-dose ipilimumab and nivolumab in patients with microsatellite stable (MSS), MGMT silenced metastatic colorectal cancer (mCRC)
ANNALS OF ONCOLOGY
IF65.4
2021-09-0113
OAAI
Pietrantonio, F.; Morano, F.; Lonardi, S.; Raimondi, A.; Salvatore, L.; Marmorino, F.; Murgioni, S.; Pella, N.; Antonuzzo, L.; Ritorto, G.; Zaniboni, A.; Ratti, M.; Palermo, F.; Pagani, F.; Prisciandaro, M.; Cagnazzo, C.; Capone, I.; Milione, M.; Di Bartolomeo, M.; de Braud, F.

研究方向

暂未获取到该数据
S
Sara Lonardi
H 指数:83论文数:1,229被引数:3.5万
F
Francesca Bergamo
H 指数:47论文数:566被引数:9,022
F
Filippo Pietrantonio
H 指数:61论文数:1,036被引数:1.6万
M
Matteo Fassan
H 指数:90论文数:1,205被引数:4.3万
F
Fotios Loupakis
H 指数:71论文数:696被引数:2.3万
F
Floriana Nappo
H 指数:12论文数:44被引数:727
C
Chiara Cremolini
H 指数:65论文数:976被引数:2.0万
L
Lisa Salvatore
H 指数:41论文数:482被引数:7,917
F
Federica Marmorino
H 指数:30论文数:186被引数:3,643
M
Mario Scartozzi
H 指数:56论文数:1,176被引数:1.2万